Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Provided By GlobeNewswire
Last update: Oct 21, 2025
CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to report third quarter 2025 financial results and discuss recent business highlights.
Read more at globenewswire.com
